Estimation of the distribution of longitudinal biomarker trajectories prior to disease progression
Estimation of the distribution of longitudinal biomarker trajectories prior to disease progression
Most studies characterize longitudinal biomarker trajectories by looking forward at them from a commonly used time origin, such as the initial treatment time. For a better understanding of the relationship between biomarkers and disease progression, we propose to align all subjects by using their disease progression time as the origin …